aluates Reports

$ 0.0

Automative

Global AI Chronic Disease Management Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-22K19615

BUY CHAPTERS

Global AI Chronic Disease Management Market Research Report 2025

Code: QYRE-Auto-22K19615

Report

September 2025

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

AI Chronic Disease Management Market Size

The global market for AI Chronic Disease Management was valued at US$ 1550 million in the year 2024 and is projected to reach a revised size of US$ 5056 million by 2031, growing at a CAGR of 18.4% during the forecast period.

AI Chronic Disease Management Market

AI chronic disease management uses artificial intelligence (AI) to digitally and intelligently manage the entire lifecycle of chronic diseases (such as diabetes, hypertension, coronary heart disease, and chronic obstructive pulmonary disease). Its core approach involves real-time collection and analysis of patients' electronic medical records, test data, wearable device monitoring information, and lifestyle data through big data, machine learning, natural language processing, knowledge graphs, and intelligent algorithms. This enables disease risk prediction, personalized intervention, medication guidance, rehabilitation tracking, and remote follow-up. Compared to traditional manual management, AI chronic disease management can significantly improve diagnosis and treatment efficiency, reduce physician burden, lower medical costs, and help patients develop long-term healthy behaviors. It has broad application value in smart hospitals, internet medical platforms, medical insurance cost control, and family health management, and is a key direction for the future development of digital healthcare and precision medicine.

North American market for AI Chronic Disease Management is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for AI Chronic Disease Management is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for AI Chronic Disease Management in Home is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of AI Chronic Disease Management include Teladoc Health, S3 Connected Health, Cognizant, Omada Health, WellDoc, Epic Systems, Pathmate, EveryDose, Aptar Digital Health, VITech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for AI Chronic Disease Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Chronic Disease Management.

The AI Chronic Disease Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Chronic Disease Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI Chronic Disease Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI Chronic Disease Management Market Report

Report Metric	Details
Report Name	AI Chronic Disease Management Market
Accounted market size in year	US$ 1550 million
Forecasted market size in 2031	US$ 5056 million
CAGR	18.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Mobile Applications Wearable Hardware Cloud Platform Others
Segment by Application	Home Commercial Medical Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teladoc Health, S3 Connected Health, Cognizant, Omada Health, WellDoc, Epic Systems, Pathmate, EveryDose, Aptar Digital Health, VITech, Virta Health, Glooko, Dexcom, Philips, Siemens, Assure Tech, Alibaba Group, Ping An Insurance, Fangzhou Inc, Jianhai Technology, Lepu Medical, Sinocare, Xunfei Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Chronic Disease Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AI Chronic Disease Management Market growing?

Ans: The AI Chronic Disease Management Market witnessing a CAGR of 18.4% during the forecast period 2025-2031.

What is the AI Chronic Disease Management Market size in 2031?

Ans: The AI Chronic Disease Management Market size in 2031 will be US$ 5056 million.

Who are the main players in the AI Chronic Disease Management Market report?

Ans: The main players in the AI Chronic Disease Management Market are Teladoc Health, S3 Connected Health, Cognizant, Omada Health, WellDoc, Epic Systems, Pathmate, EveryDose, Aptar Digital Health, VITech, Virta Health, Glooko, Dexcom, Philips, Siemens, Assure Tech, Alibaba Group, Ping An Insurance, Fangzhou Inc, Jianhai Technology, Lepu Medical, Sinocare, Xunfei Healthcare

What are the Application segmentation covered in the AI Chronic Disease Management Market report?

Ans: The Applications covered in the AI Chronic Disease Management Market report are Home, Commercial, Medical, Others

What are the Type segmentation covered in the AI Chronic Disease Management Market report?

Ans: The Types covered in the AI Chronic Disease Management Market report are Mobile Applications, Wearable Hardware, Cloud Platform, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Chronic Disease Management Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Mobile Applications

1.2.3 Wearable Hardware

1.2.4 Cloud Platform

1.2.5 Others

1.3 Market by Application

1.3.1 Global AI Chronic Disease Management Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Home

1.3.3 Commercial

1.3.4 Medical

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI Chronic Disease Management Market Perspective (2020-2031)

2.2 Global AI Chronic Disease Management Growth Trends by Region

2.2.1 Global AI Chronic Disease Management Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 AI Chronic Disease Management Historic Market Size by Region (2020-2025)

2.2.3 AI Chronic Disease Management Forecasted Market Size by Region (2026-2031)

2.3 AI Chronic Disease Management Market Dynamics

2.3.1 AI Chronic Disease Management Industry Trends

2.3.2 AI Chronic Disease Management Market Drivers

2.3.3 AI Chronic Disease Management Market Challenges

2.3.4 AI Chronic Disease Management Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Chronic Disease Management Players by Revenue

3.1.1 Global Top AI Chronic Disease Management Players by Revenue (2020-2025)

3.1.2 Global AI Chronic Disease Management Revenue Market Share by Players (2020-2025)

3.2 Global Top AI Chronic Disease Management Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by AI Chronic Disease Management Revenue

3.4 Global AI Chronic Disease Management Market Concentration Ratio

3.4.1 Global AI Chronic Disease Management Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Chronic Disease Management Revenue in 2024

3.5 Global Key Players of AI Chronic Disease Management Head office and Area Served

3.6 Global Key Players of AI Chronic Disease Management, Product and Application

3.7 Global Key Players of AI Chronic Disease Management, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 AI Chronic Disease Management Breakdown Data by Type

4.1 Global AI Chronic Disease Management Historic Market Size by Type (2020-2025)

4.2 Global AI Chronic Disease Management Forecasted Market Size by Type (2026-2031)

5 AI Chronic Disease Management Breakdown Data by Application

5.1 Global AI Chronic Disease Management Historic Market Size by Application (2020-2025)

5.2 Global AI Chronic Disease Management Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America AI Chronic Disease Management Market Size (2020-2031)

6.2 North America AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America AI Chronic Disease Management Market Size by Country (2020-2025)

6.4 North America AI Chronic Disease Management Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Chronic Disease Management Market Size (2020-2031)

7.2 Europe AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe AI Chronic Disease Management Market Size by Country (2020-2025)

7.4 Europe AI Chronic Disease Management Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI Chronic Disease Management Market Size (2020-2031)

8.2 Asia-Pacific AI Chronic Disease Management Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific AI Chronic Disease Management Market Size by Region (2020-2025)

8.4 Asia-Pacific AI Chronic Disease Management Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI Chronic Disease Management Market Size (2020-2031)

9.2 Latin America AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America AI Chronic Disease Management Market Size by Country (2020-2025)

9.4 Latin America AI Chronic Disease Management Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Chronic Disease Management Market Size (2020-2031)

10.2 Middle East & Africa AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa AI Chronic Disease Management Market Size by Country (2020-2025)

10.4 Middle East & Africa AI Chronic Disease Management Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teladoc Health

11.1.1 Teladoc Health Company Details

11.1.2 Teladoc Health Business Overview

11.1.3 Teladoc Health AI Chronic Disease Management Introduction

11.1.4 Teladoc Health Revenue in AI Chronic Disease Management Business (2020-2025)

11.1.5 Teladoc Health Recent Development

11.2 S3 Connected Health

11.2.1 S3 Connected Health Company Details

11.2.2 S3 Connected Health Business Overview

11.2.3 S3 Connected Health AI Chronic Disease Management Introduction

11.2.4 S3 Connected Health Revenue in AI Chronic Disease Management Business (2020-2025)

11.2.5 S3 Connected Health Recent Development

11.3 Cognizant

11.3.1 Cognizant Company Details

11.3.2 Cognizant Business Overview

11.3.3 Cognizant AI Chronic Disease Management Introduction

11.3.4 Cognizant Revenue in AI Chronic Disease Management Business (2020-2025)

11.3.5 Cognizant Recent Development

11.4 Omada Health

11.4.1 Omada Health Company Details

11.4.2 Omada Health Business Overview

11.4.3 Omada Health AI Chronic Disease Management Introduction

11.4.4 Omada Health Revenue in AI Chronic Disease Management Business (2020-2025)

11.4.5 Omada Health Recent Development

11.5 WellDoc

11.5.1 WellDoc Company Details

11.5.2 WellDoc Business Overview

11.5.3 WellDoc AI Chronic Disease Management Introduction

11.5.4 WellDoc Revenue in AI Chronic Disease Management Business (2020-2025)

11.5.5 WellDoc Recent Development

11.6 Epic Systems

11.6.1 Epic Systems Company Details

11.6.2 Epic Systems Business Overview

11.6.3 Epic Systems AI Chronic Disease Management Introduction

11.6.4 Epic Systems Revenue in AI Chronic Disease Management Business (2020-2025)

11.6.5 Epic Systems Recent Development

11.7 Pathmate

11.7.1 Pathmate Company Details

11.7.2 Pathmate Business Overview

11.7.3 Pathmate AI Chronic Disease Management Introduction

11.7.4 Pathmate Revenue in AI Chronic Disease Management Business (2020-2025)

11.7.5 Pathmate Recent Development

11.8 EveryDose

11.8.1 EveryDose Company Details

11.8.2 EveryDose Business Overview

11.8.3 EveryDose AI Chronic Disease Management Introduction

11.8.4 EveryDose Revenue in AI Chronic Disease Management Business (2020-2025)

11.8.5 EveryDose Recent Development

11.9 Aptar Digital Health

11.9.1 Aptar Digital Health Company Details

11.9.2 Aptar Digital Health Business Overview

11.9.3 Aptar Digital Health AI Chronic Disease Management Introduction

11.9.4 Aptar Digital Health Revenue in AI Chronic Disease Management Business (2020-2025)

11.9.5 Aptar Digital Health Recent Development

11.10 VITech

11.10.1 VITech Company Details

11.10.2 VITech Business Overview

11.10.3 VITech AI Chronic Disease Management Introduction

11.10.4 VITech Revenue in AI Chronic Disease Management Business (2020-2025)

11.10.5 VITech Recent Development

11.11 Virta Health

11.11.1 Virta Health Company Details

11.11.2 Virta Health Business Overview

11.11.3 Virta Health AI Chronic Disease Management Introduction

11.11.4 Virta Health Revenue in AI Chronic Disease Management Business (2020-2025)

11.11.5 Virta Health Recent Development

11.12 Glooko

11.12.1 Glooko Company Details

11.12.2 Glooko Business Overview

11.12.3 Glooko AI Chronic Disease Management Introduction

11.12.4 Glooko Revenue in AI Chronic Disease Management Business (2020-2025)

11.12.5 Glooko Recent Development

11.13 Dexcom

11.13.1 Dexcom Company Details

11.13.2 Dexcom Business Overview

11.13.3 Dexcom AI Chronic Disease Management Introduction

11.13.4 Dexcom Revenue in AI Chronic Disease Management Business (2020-2025)

11.13.5 Dexcom Recent Development

11.14 Philips

11.14.1 Philips Company Details

11.14.2 Philips Business Overview

11.14.3 Philips AI Chronic Disease Management Introduction

11.14.4 Philips Revenue in AI Chronic Disease Management Business (2020-2025)

11.14.5 Philips Recent Development

11.15 Siemens

11.15.1 Siemens Company Details

11.15.2 Siemens Business Overview

11.15.3 Siemens AI Chronic Disease Management Introduction

11.15.4 Siemens Revenue in AI Chronic Disease Management Business (2020-2025)

11.15.5 Siemens Recent Development

11.16 Assure Tech

11.16.1 Assure Tech Company Details

11.16.2 Assure Tech Business Overview

11.16.3 Assure Tech AI Chronic Disease Management Introduction

11.16.4 Assure Tech Revenue in AI Chronic Disease Management Business (2020-2025)

11.16.5 Assure Tech Recent Development

11.17 Alibaba Group

11.17.1 Alibaba Group Company Details

11.17.2 Alibaba Group Business Overview

11.17.3 Alibaba Group AI Chronic Disease Management Introduction

11.17.4 Alibaba Group Revenue in AI Chronic Disease Management Business (2020-2025)

11.17.5 Alibaba Group Recent Development

11.18 Ping An Insurance

11.18.1 Ping An Insurance Company Details

11.18.2 Ping An Insurance Business Overview

11.18.3 Ping An Insurance AI Chronic Disease Management Introduction

11.18.4 Ping An Insurance Revenue in AI Chronic Disease Management Business (2020-2025)

11.18.5 Ping An Insurance Recent Development

11.19 Fangzhou Inc

11.19.1 Fangzhou Inc Company Details

11.19.2 Fangzhou Inc Business Overview

11.19.3 Fangzhou Inc AI Chronic Disease Management Introduction

11.19.4 Fangzhou Inc Revenue in AI Chronic Disease Management Business (2020-2025)

11.19.5 Fangzhou Inc Recent Development

11.20 Jianhai Technology

11.20.1 Jianhai Technology Company Details

11.20.2 Jianhai Technology Business Overview

11.20.3 Jianhai Technology AI Chronic Disease Management Introduction

11.20.4 Jianhai Technology Revenue in AI Chronic Disease Management Business (2020-2025)

11.20.5 Jianhai Technology Recent Development

11.21 Lepu Medical

11.21.1 Lepu Medical Company Details

11.21.2 Lepu Medical Business Overview

11.21.3 Lepu Medical AI Chronic Disease Management Introduction

11.21.4 Lepu Medical Revenue in AI Chronic Disease Management Business (2020-2025)

11.21.5 Lepu Medical Recent Development

11.22 Sinocare

11.22.1 Sinocare Company Details

11.22.2 Sinocare Business Overview

11.22.3 Sinocare AI Chronic Disease Management Introduction

11.22.4 Sinocare Revenue in AI Chronic Disease Management Business (2020-2025)

11.22.5 Sinocare Recent Development

11.23 Xunfei Healthcare

11.23.1 Xunfei Healthcare Company Details

11.23.2 Xunfei Healthcare Business Overview

11.23.3 Xunfei Healthcare AI Chronic Disease Management Introduction

11.23.4 Xunfei Healthcare Revenue in AI Chronic Disease Management Business (2020-2025)

11.23.5 Xunfei Healthcare Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global AI Chronic Disease Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Mobile Applications

Table 3. Key Players of Wearable Hardware

Table 4. Key Players of Cloud Platform

Table 5. Key Players of Others

Table 6. Global AI Chronic Disease Management Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global AI Chronic Disease Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global AI Chronic Disease Management Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global AI Chronic Disease Management Market Share by Region (2020-2025)

Table 10. Global AI Chronic Disease Management Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global AI Chronic Disease Management Market Share by Region (2026-2031)

Table 12. AI Chronic Disease Management Market Trends

Table 13. AI Chronic Disease Management Market Drivers

Table 14. AI Chronic Disease Management Market Challenges

Table 15. AI Chronic Disease Management Market Restraints

Table 16. Global AI Chronic Disease Management Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global AI Chronic Disease Management Market Share by Players (2020-2025)

Table 18. Global Top AI Chronic Disease Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Chronic Disease Management as of 2024)

Table 19. Ranking of Global Top AI Chronic Disease Management Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by AI Chronic Disease Management Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of AI Chronic Disease Management, Headquarters and Area Served

Table 22. Global Key Players of AI Chronic Disease Management, Product and Application

Table 23. Global Key Players of AI Chronic Disease Management, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global AI Chronic Disease Management Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global AI Chronic Disease Management Revenue Market Share by Type (2020-2025)

Table 27. Global AI Chronic Disease Management Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global AI Chronic Disease Management Revenue Market Share by Type (2026-2031)

Table 29. Global AI Chronic Disease Management Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global AI Chronic Disease Management Revenue Market Share by Application (2020-2025)

Table 31. Global AI Chronic Disease Management Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global AI Chronic Disease Management Revenue Market Share by Application (2026-2031)

Table 33. North America AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific AI Chronic Disease Management Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific AI Chronic Disease Management Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific AI Chronic Disease Management Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)

Table 48. Teladoc Health Company Details

Table 49. Teladoc Health Business Overview

Table 50. Teladoc Health AI Chronic Disease Management Product

Table 51. Teladoc Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 52. Teladoc Health Recent Development

Table 53. S3 Connected Health Company Details

Table 54. S3 Connected Health Business Overview

Table 55. S3 Connected Health AI Chronic Disease Management Product

Table 56. S3 Connected Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 57. S3 Connected Health Recent Development

Table 58. Cognizant Company Details

Table 59. Cognizant Business Overview

Table 60. Cognizant AI Chronic Disease Management Product

Table 61. Cognizant Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 62. Cognizant Recent Development

Table 63. Omada Health Company Details

Table 64. Omada Health Business Overview

Table 65. Omada Health AI Chronic Disease Management Product

Table 66. Omada Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 67. Omada Health Recent Development

Table 68. WellDoc Company Details

Table 69. WellDoc Business Overview

Table 70. WellDoc AI Chronic Disease Management Product

Table 71. WellDoc Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 72. WellDoc Recent Development

Table 73. Epic Systems Company Details

Table 74. Epic Systems Business Overview

Table 75. Epic Systems AI Chronic Disease Management Product

Table 76. Epic Systems Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 77. Epic Systems Recent Development

Table 78. Pathmate Company Details

Table 79. Pathmate Business Overview

Table 80. Pathmate AI Chronic Disease Management Product

Table 81. Pathmate Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 82. Pathmate Recent Development

Table 83. EveryDose Company Details

Table 84. EveryDose Business Overview

Table 85. EveryDose AI Chronic Disease Management Product

Table 86. EveryDose Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 87. EveryDose Recent Development

Table 88. Aptar Digital Health Company Details

Table 89. Aptar Digital Health Business Overview

Table 90. Aptar Digital Health AI Chronic Disease Management Product

Table 91. Aptar Digital Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 92. Aptar Digital Health Recent Development

Table 93. VITech Company Details

Table 94. VITech Business Overview

Table 95. VITech AI Chronic Disease Management Product

Table 96. VITech Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 97. VITech Recent Development

Table 98. Virta Health Company Details

Table 99. Virta Health Business Overview

Table 100. Virta Health AI Chronic Disease Management Product

Table 101. Virta Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 102. Virta Health Recent Development

Table 103. Glooko Company Details

Table 104. Glooko Business Overview

Table 105. Glooko AI Chronic Disease Management Product

Table 106. Glooko Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 107. Glooko Recent Development

Table 108. Dexcom Company Details

Table 109. Dexcom Business Overview

Table 110. Dexcom AI Chronic Disease Management Product

Table 111. Dexcom Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 112. Dexcom Recent Development

Table 113. Philips Company Details

Table 114. Philips Business Overview

Table 115. Philips AI Chronic Disease Management Product

Table 116. Philips Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 117. Philips Recent Development

Table 118. Siemens Company Details

Table 119. Siemens Business Overview

Table 120. Siemens AI Chronic Disease Management Product

Table 121. Siemens Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 122. Siemens Recent Development

Table 123. Assure Tech Company Details

Table 124. Assure Tech Business Overview

Table 125. Assure Tech AI Chronic Disease Management Product

Table 126. Assure Tech Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 127. Assure Tech Recent Development

Table 128. Alibaba Group Company Details

Table 129. Alibaba Group Business Overview

Table 130. Alibaba Group AI Chronic Disease Management Product

Table 131. Alibaba Group Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 132. Alibaba Group Recent Development

Table 133. Ping An Insurance Company Details

Table 134. Ping An Insurance Business Overview

Table 135. Ping An Insurance AI Chronic Disease Management Product

Table 136. Ping An Insurance Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 137. Ping An Insurance Recent Development

Table 138. Fangzhou Inc Company Details

Table 139. Fangzhou Inc Business Overview

Table 140. Fangzhou Inc AI Chronic Disease Management Product

Table 141. Fangzhou Inc Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 142. Fangzhou Inc Recent Development

Table 143. Jianhai Technology Company Details

Table 144. Jianhai Technology Business Overview

Table 145. Jianhai Technology AI Chronic Disease Management Product

Table 146. Jianhai Technology Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 147. Jianhai Technology Recent Development

Table 148. Lepu Medical Company Details

Table 149. Lepu Medical Business Overview

Table 150. Lepu Medical AI Chronic Disease Management Product

Table 151. Lepu Medical Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 152. Lepu Medical Recent Development

Table 153. Sinocare Company Details

Table 154. Sinocare Business Overview

Table 155. Sinocare AI Chronic Disease Management Product

Table 156. Sinocare Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 157. Sinocare Recent Development

Table 158. Xunfei Healthcare Company Details

Table 159. Xunfei Healthcare Business Overview

Table 160. Xunfei Healthcare AI Chronic Disease Management Product

Table 161. Xunfei Healthcare Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)

Table 162. Xunfei Healthcare Recent Development

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. AI Chronic Disease Management Picture

Figure 2. Global AI Chronic Disease Management Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global AI Chronic Disease Management Market Share by Type: 2024 VS 2031

Figure 4. Mobile Applications Features

Figure 5. Wearable Hardware Features

Figure 6. Cloud Platform Features

Figure 7. Others Features

Figure 8. Global AI Chronic Disease Management Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global AI Chronic Disease Management Market Share by Application: 2024 VS 2031

Figure 10. Home Case Studies

Figure 11. Commercial Case Studies

Figure 12. Medical Case Studies

Figure 13. Others Case Studies

Figure 14. AI Chronic Disease Management Report Years Considered

Figure 15. Global AI Chronic Disease Management Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global AI Chronic Disease Management Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global AI Chronic Disease Management Market Share by Region: 2024 VS 2031

Figure 18. Global AI Chronic Disease Management Market Share by Players in 2024

Figure 19. Global AI Chronic Disease Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by AI Chronic Disease Management Revenue in 2024

Figure 21. North America AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America AI Chronic Disease Management Market Share by Country (2020-2031)

Figure 23. United States AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe AI Chronic Disease Management Market Share by Country (2020-2031)

Figure 27. Germany AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Ireland AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific AI Chronic Disease Management Market Share by Region (2020-2031)

Figure 35. China AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia & New Zealand AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America AI Chronic Disease Management Market Share by Country (2020-2031)

Figure 43. Mexico AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa AI Chronic Disease Management Market Share by Country (2020-2031)

Figure 47. Israel AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Teladoc Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 51. S3 Connected Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 52. Cognizant Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 53. Omada Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 54. WellDoc Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 55. Epic Systems Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 56. Pathmate Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 57. EveryDose Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 58. Aptar Digital Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 59. VITech Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 60. Virta Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 61. Glooko Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 62. Dexcom Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 63. Philips Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 64. Siemens Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 65. Assure Tech Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 66. Alibaba Group Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 67. Ping An Insurance Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 68. Fangzhou Inc Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 69. Jianhai Technology Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 70. Lepu Medical Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 71. Sinocare Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 72. Xunfei Healthcare Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V18395

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32G20014

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global AI Chronic Disease Management Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-22K19615

Global AI Chronic Disease Management Market Research Report 2025

FEATURED COMPANIES

AI Chronic Disease Management Market Size

AI Chronic Disease Management Market

Scope of AI Chronic Disease Management Market Report

Chapter Outline

FAQ for this report

How fast is AI Chronic Disease Management Market growing?

What is the AI Chronic Disease Management Market size in 2031?

Who are the main players in the AI Chronic Disease Management Market report?

What are the Application segmentation covered in the AI Chronic Disease Management Market report?

What are the Type segmentation covered in the AI Chronic Disease Management Market report?

FEATURED COMPANIES

RELATED REPORTS